losartan and metallothionein

losartan has been researched along with metallothionein in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Epstein, PN; Metreveli, NS; Ren, J; Ye, G	1
Al-Ismaeel, H; Al-Rikabi, AC; Al-Shabanah, OA; Mansour, MA	1

Other Studies

2 other study(ies) available for losartan and metallothionein

Article	Year
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production. Diabetes, 2003, Volume: 52, Issue:3 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Gene Expression; Glucose; Losartan; Metallothionein; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; NADPH Oxidases; Onium Compounds; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Spectrometry, Fluorescence	2003
Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver. Life sciences, 2011, Aug-01, Volume: 89, Issue:5-6 Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A	2011

Article

Year

Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.

Diabetes, 2003, Volume: 52, Issue:3

Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Gene Expression; Glucose; Losartan; Metallothionein; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; NADPH Oxidases; Onium Compounds; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Spectrometry, Fluorescence

2003

Comparison of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor blockade for the prevention of premalignant changes in the liver.

Life sciences, 2011, Aug-01, Volume: 89, Issue:5-6

Topics: alpha-Fetoproteins; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticarcinogenic Agents; Captopril; Carcinoembryonic Antigen; Endostatins; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Hydroxyproline; Liver; Liver Neoplasms, Experimental; Losartan; Male; Matrix Metalloproteinase 2; Metallothionein; Perindopril; Precancerous Conditions; Rats; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A

2011